Japanese clinic websites rarely show patient testimonials or before-and-after galleries because Japan's Medical Care Act and the Ministry of Health, Labour and Welfare's Medical Advertising Guidelines (last revised March 30, 2026) ban testimonials based on patients' subjective impressions and before-and-after photos that could mislead people about results. Before-and-after photos are not banned outright: they can appear only on a page patients seek out themselves, that gives a way to ask questions, and that sets out the treatment, cost, main risks and side effects right next to the photos.
For a patient comparing clinics from abroad, that changes what to look for. On a Japanese clinic's site, the useful signals are whether cost, course length, risks and side effects are clearly stated, and whether the page uses phrases like "No. 1 in Japan" or "approved by the Ministry of Health."
What Japan prohibits in clinic advertising
The core rule is Article 6-5 of the Medical Care Act, filled out by the Act's Enforcement Regulations and the MHLW guidelines.
False advertising is banned outright. Anyone advertising medical practice or a hospital or clinic, by any method, may not make false claims. The guidelines give an example: before-and-after photos that have been edited or retouched to make a treatment look effective count as false advertising.
Five further categories are prohibited. The guidelines group them as follows:
| Category | What it means | Key point in the guidelines |
|---|---|---|
| Comparative superiority | Claiming to be better than other hospitals or clinics | Superlatives such as "No. 1 in Japan," "No.1" or "the best" are prohibited even when objectively true |
| Exaggeration | Overstating facts so results seem better than they are | See the regenerative medicine examples below |
| Contrary to public order or morals | Content that offends public order or decency | A general provision |
| Testimonials | Patients describing a treatment or its results based on subjective impressions or hearsay | Each patient's condition differs, so their impressions differ, and testimonials easily mislead |
| Misleading before-and-after photos | Showing results with photos taken before and after treatment | Results vary from patient to patient |
The first three categories come from Article 6-5(2) of the Act; the testimonial and photo bans are in Article 1-9 of the Enforcement Regulations.
Why testimonials are out entirely. Patients' conditions differ, so their experiences differ, and a testimonial a clinic uses to attract patients invites readers to expect the same result. Even if what the testimonial says would otherwise be allowed in an ad, it is not permitted as medical advertising. There is one distinction. A patient's own website, social media account or post on an independent review site is not the clinic's advertising, provided the clinic has not paid for it or otherwise arranged it.
Websites are covered. The 2017 amendment to the Medical Care Act (Act No. 57 of 2017) widened the rules from "advertising" to "advertising and other representations intended to attract patients," effective June 1, 2018. Since then, a clinic's website is regulated like any other medium, and false or exaggerated claims on it can lead to correction orders and penalties.
That is the main reason Japanese clinic sites look so different from sites that lead with patient stories and photo galleries.
When before-and-after photos are allowed
The answer comes in three layers.

First, treatment results are not something a clinic may freely advertise. In ordinary advertising, such as a station poster or an online banner, a clinic cannot use before-and-after photos to show results.
Second, the rules allow an exception, known as "lifting the restriction" (gentei kaijo), for information that patients look for themselves. Under Article 1-9-2 of the Enforcement Regulations, all four conditions must be met:
- The information is on a website or similar medium that patients seek out themselves to make an informed choice about care.
- The page gives a way to contact the clinic with questions about its content.
- For private (self-pay) care, the page states the usual treatment and its cost.
- For private care, the page states the main risks and side effects.
Conditions 3 and 4 apply only when the page describes private care. The guidelines add that banner ads, sponsored links shown in search results and paid top placements are not something patients seek out themselves, so they fail condition 1.
Third, even where the exception applies, a before-and-after photo must be accompanied by a detailed explanation of the usual treatment, its cost and its main risks and side effects. That explanation cannot sit on a separate linked page, and it cannot be in much smaller type than the information about benefits. The guidelines list photos or illustrations shown with too little explanation as an example of what is prohibited.
So when you see a before-and-after photo, look at what surrounds it. If the treatment, cost, risks and side effects are not set out right there, the page does not meet the guidelines.
What a private-care page has to state
Most stem cell, exosome and immune cell treatments in Japan are private care: outside public health insurance, priced by the clinic and paid in full by the patient (see Why Regenerative Treatment in Japan Is Self-Pay). When a clinic describes private care on a page that relies on the exception, the guidelines set two specific requirements:
- Treatment and cost. The page must give the usual treatment, the standard fee, the treatment period and the number of sessions. If the standard fee is hard to pin down, it must give a range from the lowest to the highest amount, including common additional charges, in a form patients can follow.
- Risks and side effects. The page may not stress benefits alone. The main risks and side effects must be presented just as clearly.
A page that shows only a starting price, with no course length or number of sessions, or that lists benefits with no risks or side effects, is giving you incomplete information.
Rules that apply directly to regenerative medicine
The MHLW's Q&A on the guidelines and its Case Commentary on Website Advertising (6th edition, issued March 30, 2026 and based on violations found in actual monitoring) address regenerative medicine directly:

Treatments using unapproved products generally cannot be advertised. A treatment that uses only regenerative medicine products approved under Japan's pharmaceutical law, used as approved, can be advertised. Regenerative treatment using unapproved products cannot. It can be described only on a page that meets the exception, and that page must also state that the product is unapproved, how it was obtained, whether an approved equivalent exists in Japan, safety information from overseas, and that harm from it falls outside Japan's relief system for adverse drug reactions.
No claims of matching or beating standard treatment. Saying or implying that private-care "regenerative medicine" is as effective or safe as standard treatment, or more so, is exaggerated advertising.
No promoting the effects of exosomes or culture supernatant. The Case Commentary states that the effectiveness and safety of exosomes and cell culture supernatant have not been confirmed by the MHLW or by regulators in other countries, and lists advertising that stresses their effects to attract patients as an example of a violation. For the state of the research, see Exosome Therapy: What It Is and How Much Evidence There Is for Skin and Anti-Aging.
A filed plan is not ministry approval. A provision plan under the Act on the Safety of Regenerative Medicine is reviewed by a certified committee and then submitted to the Minister of Health, Labour and Welfare. The Minister does not approve or vouch for the effectiveness or safety of any individual plan. Wording that suggests a treatment has special MHLW certification or approval is exaggerated advertising. Filing a plan is a legal requirement for the clinic, and how to confirm it is covered in How to Tell Whether a Japanese Regenerative Medicine Clinic Is Compliant.
What happens when a clinic breaks the rules
The guidelines set the usual sequence. When a prefecture, a city with a public health center or a special ward finds a violating ad, it normally starts with administrative guidance asking the clinic to stop or correct it. If the clinic does not comply, or keeps violating, the authority can issue an order under Article 6-8 of the Act to stop or correct the ad by a deadline. It can also require reports and inspect the premises.
Penalties under the Medical Care Act, as the provisions read in 2026:
- False advertising, or breaching an order to stop or correct: imprisonment of up to six months or a fine of up to 300,000 yen (Article 87, as in force in 2026).
- Failing to report, reporting falsely, or refusing or obstructing an inspection: a fine of up to 200,000 yen (Article 89, as in force in 2026).
For serious cases, the guidelines also mention administrative action beyond a criminal complaint, including replacing a clinic's manager, revoking its license to operate or ordering it closed for a period. The MHLW also funds a monitoring program, the Medical Institution Net Patrol, that checks clinic websites for false or exaggerated claims.
A checklist for reading a Japanese clinic's website
Read a clinic's page against the rules:

- Patient testimonials. Testimonials a clinic publishes itself are not permitted, so don't treat them as evidence.
- Explanations next to photos. Treatment, cost, risks and side effects should sit beside any before-and-after photo in normal-size type. Photos with no explanation, or with the explanation behind a link, fall short.
- Superlatives. "No. 1," "the best" and similar claims are prohibited even when true.
- How fully cost is stated. Look for a standard fee or a full range, the course length and number of sessions, and common extra charges. If only a starting price is shown, ask.
- Where risks and side effects appear. They should be as easy to find as the benefits.
- "Approved by the Ministry" claims. A filed provision plan is a legal procedure, not an endorsement of results.
- Claims of beating standard treatment. For regenerative medicine, these count as exaggeration.
- Unapproved products. If one is used, the page should say so and give the source and overseas safety information.
A website can only help you rule out claims that clearly break the rules; whether a clinic and treatment suit you depends on its filed plan and written explanation document. You can hand that step to us: send the clinic's name, the page you saw and the treatment you were offered to our advisors. We'll check whether it has filed a provision plan for that treatment and whether the cost and risk information in its documents is complete, then match you with suitable Japanese hospitals and doctors and arrange a remote video consultation. Consultation and coordination are free. For the regulatory framework, see How Japan regulates regenerative medicine, and for common sales tactics, see Stem Cell Clinic Scams: How to Tell Legitimate Treatment From Marketing Claims.
Frequently asked questions
Can a Japanese clinic's website show before-and-after photos?
Yes, but under strict conditions. The photos can appear only on a page patients seek out themselves, that gives a way to ask questions, and that sets out the usual treatment, cost, main risks and side effects right beside them. Banner ads and paid search ads cannot use them to show results, and retouched photos count as false advertising.
Do patients' own social media posts break the rules?
Not necessarily. A patient's own website, social media account or post on an independent review site is not the clinic's advertising, as long as the clinic did not pay for it or arrange it. Testimonials a clinic publishes to attract patients are not permitted.
If a clinic really is "No. 1 in Japan," can it say so?
No. The guidelines state that superlatives such as "No. 1 in Japan," "No.1" and "the best" are prohibited comparative claims even when they are objectively true.
A clinic says its treatment is "approved by the Ministry of Health." What does that mean?
Ask exactly what it refers to. A regenerative medicine clinic files a provision plan, which is a legal procedure; the Minister does not approve or vouch for the effectiveness or safety of individual plans. Presenting a filed plan as special ministry approval is exaggerated advertising.
What are the penalties for breaking Japan's medical advertising rules?
Usually the local authority starts with guidance, then issues orders if the clinic does not comply. False advertising or breaching an order can bring imprisonment of up to six months or a fine of up to 300,000 yen under the Act as in force in 2026, and serious cases can lead to license revocation or closure.
Sources: Medical Care Act (Act No. 205 of 1948), Articles 6-5, 6-8, 87 and 89, and its Enforcement Regulations, Articles 1-9 and 1-9-2 (e-Gov, provisions in force October 1, 2026); MHLW, Medical Advertising Guidelines (last revised March 30, 2026) and the Q&A on the guidelines; MHLW, Case Commentary on Website Advertising under the Medical Advertising Rules, 6th edition (March 30, 2026); MHLW Medical Institution Net Patrol. Checked November 2026; MHLW publications prevail.
Medical disclaimer: This site provides general information only and does not constitute medical advice; whether any treatment is suitable for you must be decided by a doctor after an in-person consultation.